These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15934305)

  • 21. Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.
    Chu TH; Chan HH; Kuo HM; Liu LF; Hu TH; Sun CK; Kung ML; Lin SW; Wang EM; Ma YL; Cheng KH; Lai KH; Wen ZH; Hsu PI; Tai MH
    Oncotarget; 2014 Mar; 5(6):1475-90. PubMed ID: 24721996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of COX-2 inhibitor celecoxib on proliferation, apoptosis of HL-60 cells and its mechanism].
    Xie X; Li J; Wang RC; Geng RL; Wang SY; Wang C; Zhao XY; Hao HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):707-11. PubMed ID: 24989281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.
    Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
    J Neurosurg; 2005 Sep; 103(3):508-17. PubMed ID: 16235684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis.
    Gallouet AS; Travert M; Bresson-Bepoldin L; Guilloton F; Pangault C; Caulet-Maugendre S; Lamy T; Tarte K; Guillaudeux T
    Clin Cancer Res; 2014 May; 20(10):2663-73. PubMed ID: 24637636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Celecoxib increased cellular ATRA sensitivity of human colon cancer cell lines through COX-2-independent mechanisms].
    Liu JP; Wei HB; Zheng ZH; Guo WP; Fang JF
    Yao Xue Xue Bao; 2009 Dec; 44(12):1353-8. PubMed ID: 21351468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
    Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
    Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of Celecoxib and Sc-58125 on proliferation of human carcinoma of larynx Hep-2 in vitro.
    Ding J; Chang Q; Gong S
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):202-5. PubMed ID: 16116973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproliferative effects of celecoxib in Hep-2 cells through telomerase inhibition and induction of apoptosis.
    Zhao YQ; Feng HW; Jia T; Chen XM; Zhang H; Xu AT; Zhang HL; Fan XL
    Asian Pac J Cancer Prev; 2014; 15(12):4919-23. PubMed ID: 24998564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells.
    Wang X; Li G; Wang A; Zhang Z; Merchan JR; Halmos B
    Mol Carcinog; 2013 Mar; 52(3):218-28. PubMed ID: 22121107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of celecoxib on proliferation, apoptosis, and survivin expression in human glioma cell line U251.
    Zhou R; Zhang LZ; Wang RZ
    Chin J Cancer; 2010 Mar; 29(3):294-9. PubMed ID: 20193113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of celecoxib on PGE2 synthesis and COX-2 and VEGF-C mRNA expression in Tca8113 cell lines].
    Li WZ; Wang XY; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):466-8. PubMed ID: 19304526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of celecoxib on enhancing the chemotherapic sensitivity of hydroxyurea to K562 cells and its mechanism].
    Liu DS; Zhang GS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):495-9. PubMed ID: 16137030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.
    Song X; Lin HP; Johnson AJ; Tseng PH; Yang YT; Kulp SK; Chen CS
    J Natl Cancer Inst; 2002 Apr; 94(8):585-91. PubMed ID: 11959891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
    Cianchi F; Cortesini C; Magnelli L; Fanti E; Papucci L; Schiavone N; Messerini L; Vannacci A; Capaccioli S; Perna F; Lulli M; Fabbroni V; Perigli G; Bechi P; Masini E
    Mol Cancer Ther; 2006 Nov; 5(11):2716-26. PubMed ID: 17121918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
    Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
    Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro.
    Chuang HC; Kardosh A; Gaffney KJ; Petasis NA; Schönthal AH
    Mol Cancer; 2008 May; 7():38. PubMed ID: 18485224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of PGE2 by physiologic levels of celecoxib is not sufficient to induce apoptosis or inhibit cell proliferation in human colon carcinoma cell lines.
    Lev-Ari S; Kazanov D; Liberman E; Ben-Yosef R; Arber N
    Dig Dis Sci; 2007 Apr; 52(4):1128-33. PubMed ID: 17342386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor.
    Yoshino T; Kimoto A; Kobayashi S; Noguchi M; Fukunaga M; Hayashi A; Miyata K; Sasamata M
    Arzneimittelforschung; 2005; 55(7):394-402. PubMed ID: 16080279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.